# Quidel Corporation

Quidel Corporation is an In Vitro Diagnostics based in San Diego, United States.

## Overview

- **Organization type:** In Vitro Diagnostics
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** San Diego, CA, United States
- **Founded:** 1979
- **Assets under management:** Undisclosed
- **Website:** quidel.com
- **LinkedIn:** https://www.linkedin.com/company/quidel-corporation

## Regulatory record

- **Reports private funds:** No

## About

Quidel Corporation was founded in 1979 by Kenneth Buechler in San Diego as a developer of rapid diagnostic tests. The company went public in 1985 and has since expanded through organic growth and acquisitions, including the 2022 merger with Ortho Clinical Diagnostics in a $5.1B deal, 2022). Wealth origin is tied to founder equity and public-market value, not a single-family fortune. Quidel's strategy centers on point-of-care diagnostics across respiratory illness, infectious disease, and women's health. The company manufactures and sells immunoassay and molecular testing platforms — including the Sofia and Lyra product lines — to hospitals, clinics, and laboratories globally. Geographically, Quidel has a presence in North America, Europe, and Asia, with its diagnostic kits distributed through commercial partnerships and direct sales. As of 2026, Quidel employs over 5,000 people and operates R&D and manufacturing facilities in San Diego and Rochester, New York. The firm has not disclosed an AUM or deployment figure; it functions as a publicly traded corporation with a market capitalization of approximately $3.5B (per Yahoo Finance, 2026). No distinct family office, philanthropic foundation, or adjacent vehicle has been publicly reported separate from the corporate entity. The structural differentiator for Quidel is its public-company governance and scale: it is not a family office but a publicly held diagnostics firm. This structure provides access to capital markets and a broad shareholder base, distinct from the closed, private-equity-like posture of most family offices. Succession and leadership transitions follow corporate governance norms rather than family trust structures.

## Sectors

- Healthcare Services
- Life Sciences

## People

- Kenneth Buechler — Founder

## Questions

### Who controls Quidel Corporation?

Quidel is a publicly traded company (NASDAQ: QDEL). While founder Kenneth Buechler had significant influence early on, the firm is now governed by a board of directors and managed by an executive team accountable to public shareholders.

### What is Quidel's primary business focus?

Quidel develops and sells rapid diagnostic tests for infectious diseases, with strong positions in respiratory illnesses, influenza, and COVID-19. Its product portfolio includes the Sofia immunoassay platform and molecular diagnostic systems.

### Does Quidel operate globally?

Yes. While its headquarters and primary R&D are in San Diego, Quidel has commercial operations in Europe and Asia. The company also has manufacturing in Rochester, New York, post-merger with Ortho Clinical Diagnostics.

## Related profiles

- [Arxada Ltd./Troy Corporation](https://altss.com/profile/arxada-ltdtroy-corporation)
- [Oracle Corporation](https://altss.com/profile/oracle-corporation)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/quidel-corporation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology